博拓生物(688767) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 reached ¥135,626,648.51, representing a year-on-year increase of 30.81%[5] - Net profit attributable to shareholders was ¥39,631,348.59, showing a significant growth of 233.05% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was ¥39,439,732.29, reflecting a remarkable increase of 335.55%[5] - Basic earnings per share (EPS) stood at ¥0.38, which is an increase of 245.45% year-on-year[6] - Total operating revenue for Q1 2024 reached ¥135,626,648.51, a 30.8% increase from ¥103,685,805.87 in Q1 2023[23] - Net profit for Q1 2024 was ¥39,534,332.13, compared to ¥11,502,242.39 in Q1 2023, representing a significant increase of 243.5%[24] - Basic and diluted earnings per share for Q1 2024 were both ¥0.38, up from ¥0.11 in Q1 2023[25] - The company reported a total comprehensive income of ¥39,790,478.52 for Q1 2024, compared to ¥12,210,106.37 in Q1 2023, marking an increase of 226.5%[25] Research and Development - The total R&D investment amounted to ¥14,645,403.84, accounting for 10.80% of the revenue, an increase of 1.27 percentage points from the previous year[6] - Research and development expenses increased to ¥14,645,403.84 in Q1 2024, compared to ¥9,880,272.83 in Q1 2023, reflecting a 48.3% rise[23] Cash Flow and Liquidity - The net cash flow from operating activities was ¥56,524,065.34, with no applicable year-on-year comparison[5] - Cash flow from operating activities generated a net inflow of ¥56,524,065.34, a turnaround from a net outflow of ¥20,061,528.63 in the same period last year[28] - The net cash flow from investing activities was -158,167,545.39 CNY, indicating a significant outflow compared to the previous quarter's -9,292,153.48 CNY[29] - The total cash and cash equivalents at the end of the period were 1,765,712,542.46 CNY, down from 1,907,238,695.68 CNY at the beginning of the period[30] - The cash outflow from financing activities totaled 40,676,446.42 CNY, with a net cash flow from financing activities of -40,676,446.42 CNY[29] - The cash and cash equivalents decreased by 141,526,153.22 CNY during the quarter, reflecting a challenging cash flow environment[29] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,574,183,807.27, a slight decrease of 0.21% from the end of the previous year[6] - The company's cash and cash equivalents decreased to RMB 1,765,904,542.46 from RMB 1,907,430,695.68, reflecting a decline of approximately 7.4%[18] - Accounts receivable stood at RMB 60,565,920.29, down from RMB 61,888,543.95, indicating a decrease of about 2.1%[18] - The total current liabilities decreased to RMB 188,000,000.00 from RMB 189,000,000.00, showing a reduction of approximately 0.5%[19] - The total liabilities decreased to ¥153,172,237.72 from ¥158,820,879.74, indicating a reduction of approximately 3.9%[20] - The total equity attributable to shareholders increased slightly to ¥2,415,596,726.30 from ¥2,415,243,484.16, showing a marginal growth[20] Shareholder Information - The company reported a total of 7,673 common shareholders at the end of the reporting period[12] - The company reported a total of 10 major shareholders, with Hangzhou Tuokang Investment Co., Ltd. being the controlling shareholder[15] Share Repurchase - The company repurchased a total of 2,000,000 shares, representing 1.875% of the total share capital, with a total expenditure of RMB 54,273,421.33[15] - The highest repurchase price was RMB 33.48 per share, while the lowest was RMB 22.23 per share[15] Fixed Assets and Inventory - Fixed assets increased significantly to RMB 383,339,067.77 from RMB 220,573,094.57, reflecting an increase of about 73.7%[19] - Inventory decreased to RMB 81,513,475.04 from RMB 99,323,982.27, indicating a decline of approximately 17.9%[18] Management and Accounting - The company has not adopted new accounting standards for the current fiscal year, maintaining consistency in financial reporting[30] - The company’s management team includes Chen Yinlong as the responsible person and Yu Miaomiao as the accounting head, ensuring oversight of financial operations[30]